In contrast, increasing SOD activity using recombinant SOD, SOD overexpression, or SOD mimetics was shown to enhance radiation responses in a wide array of tumor cells, including fibrosarcoma, squamous cell carcinoma, brain, and breast cancer [28,29,30]. This evidence concerns the gene SOD1 and squamous cell carcinoma.